| Title |
Author |
Type |
Date |
Words |
| Role for DHA in Alzheimer's Disease. |
|
Brief article |
May 1, 2008 |
256 |
| Cactus power! |
|
Brief article |
May 1, 2008 |
265 |
| High concentration natural astaxanthin. |
|
Brief article |
May 1, 2008 |
184 |
| Blood test may detect early breast cancer. |
McBride, Deborah |
Brief article |
Apr 1, 2008 |
189 |
| S.D.'s biotech beginnings traced to Hybritech; many of firm's former execs started their own successful companies. |
Weeks, Katie |
|
Aug 15, 2005 |
972 |
| What's in a name? Plenty, drug makers say: firms hire wordsmiths to market new products. |
Webb, Marion |
|
Jul 18, 2005 |
1022 |
| Choose life: grow young with HGH. |
|
Advertisement |
Jun 1, 2005 |
830 |
| Priority review is a coup. |
Webb, Marion |
|
Apr 11, 2005 |
176 |
| DNAPrint genomics to discuss role of biological ancestry in criminal investigations. |
|
|
Apr 1, 2005 |
438 |
| Keratec Limited. |
|
Company Profile |
Mar 1, 2005 |
290 |
| Martek Biosciences Corporation. |
|
Company Profile |
Mar 1, 2005 |
175 |
| Pronova Biocare A.S. |
|
Company Profile |
Mar 1, 2005 |
255 |
| US Army Medical Research Institute of Infectious Diseases purchased HTS Biosystems. |
|
Brief Article |
Feb 15, 2005 |
14 |
| Cryptome anti-thrombosis drug reduces clots in animals. |
|
|
Jan 1, 2005 |
547 |
| Cryptome to apply its drug discovery technology to neuroinflammatory diseases. |
|
|
Dec 1, 2004 |
380 |
| GPC Biotech presents data on 1D09C3 anticancer monoclonal antibody. |
|
|
Sep 1, 2004 |
558 |
| Corgentech announces patent issuance for E2F transcription factor decoy technology. |
|
Brief Article |
Aug 1, 2004 |
288 |
| Rapid diagnosis of vaginitis. |
|
Brief Article |
Jul 1, 2004 |
58 |
| CEO INTERVIEW: RUSSELL MEDFORD - ATHEROGENICS INC (AGIX). |
|
Brief Article |
Oct 21, 2003 |
88 |
| CEO INTERVIEW: BRIAN HUTCHISON - REGENERATION TECHNOLOGIES INC (RTIX). |
|
Brief Article |
Oct 21, 2003 |
90 |
| Toyo Boseki obtains United States patent. |
|
Brief Article |
Oct 1, 2003 |
153 |
| Amersham Bioscience reported that its MegaBACE system and reagents were used by the Beijing Genomics Institute of the Chinese Academy of Science and the Chinese University of Hong Kong. (Sales/Orders of Note). |
|
Brief Article |
Jul 31, 2003 |
34 |
| CEO INTERVIEW: RONALD HANDFORD - GENEMAX CORPORATION (GMXX). |
|
Brief Article |
Jul 28, 2003 |
88 |
| CEO INTERVIEW: PAUL KELLY - ORCHID BIOSCIENCES INC (ORCH). |
|
Brief Article |
Jul 28, 2003 |
89 |
| CEO INTERVIEW: TONY FRUDAKIS - DNAprint genomics INC (DNAP). |
|
Brief Article |
Jul 28, 2003 |
89 |
| CEO INTERVIEW: JACK BOWMAN - NEORX CORPORATION (NERX). |
|
Brief Article |
Jul 28, 2003 |
88 |
| CEO INTERVIEW: ROY LEVITT - GENAERA CORPORATION (GENR). |
|
Brief Article |
Jul 28, 2003 |
88 |
| CEO INTERVIEW: PAUL MANGANO - PROTERION CORPORATION (PRC). |
|
Brief Article |
Jul 28, 2003 |
88 |
| CEO INTERVIEW: HEINRICH GUGGER - PARADIGM GENETICS INC (PDGM). |
|
Brief Article |
Jul 28, 2003 |
89 |
| CEO INTERVIEW: WILLIAM HUSE - APPLIED MOLECULAR EVOLUTION (AMEV). |
|
Brief Article |
Jul 28, 2003 |
89 |
| CEO INTERVIEW: DON SEAQUIST - EMBREX INC (EMBX). |
|
Brief Article |
Jul 28, 2003 |
88 |
| CropDesign of Belgium built its protocols for plant DNA extraction. (Nucleic acid amplification: sales/orders of note). |
|
Brief Article |
Jul 15, 2003 |
24 |
| Neurocrine biosciences is pleased with success of sleeping drug test. (Biotech). |
Webb, Marion |
Brief Article |
Apr 28, 2003 |
177 |
| Myriad Genetics Inc. (Salt Lake City). |
|
Brief Article |
Dec 1, 2002 |
46 |
| SYMMETRY AORTIC CONNECTOR USED IN MORE THAN 25,000 IMPLANTS. |
|
|
Jul 1, 2002 |
700 |
| Monsanto Co. (At Closing News). |
|
Brief Article |
May 1, 2002 |
83 |
| Melanoma predictive test. (New tests). |
|
Brief Article |
Nov 1, 2001 |
149 |
| FDA clearance. (Survey results). |
|
Brief Article |
Nov 1, 2001 |
83 |
| FIBERMAX COTTON SEED: Aventis CropScience. |
Reddick, Bekah |
Brief Article |
Oct 1, 2001 |
241 |
| Mouse metabolic cage. |
|
Brief Article |
Aug 1, 2001 |
100 |
| The Mystery in Your Milk. |
Akre, Jane; Wilson, Steve |
|
Jun 22, 2001 |
4596 |
| New website from CCFRA. |
|
Brief Article |
Jun 1, 2001 |
139 |
| Landmark Alzheimer's Study Involves Local Firm. |
WEBB, MARION |
|
Apr 16, 2001 |
731 |
| GENETIC ENGINEERING FREEZE IT FOR FIVE YEARS (1). |
PHELPS, BOB |
|
Dec 1, 2000 |
2691 |
| FDA Advisory Panel Recommends Approval of Zeneca's Nolvadex -Tamoxifen Citrate- for Reduction of Incidence of Breast Cancer in Women At Increased Risk. |
|
|
Sep 2, 1998 |
800 |
| Researchers Cite Merits of Synbiotics Product. |
|
|
Aug 20, 1998 |
559 |
| Demeter BioTechnologies, Ltd. Announces its Peptidyl MIM Significantly Reduces Prostate Cancer Tumors & Mortality in Animal Models. |
|
|
Jul 23, 1998 |
825 |
| UroMed Corporation Announces 510k Submission for Brachytherapy Seeds. |
|
|
Jun 24, 1998 |
675 |
| Techniclone Announces Oncolym Presentations Made at 45th Annual Society of Nuclear Medicine Meeting. |
|
|
Jun 15, 1998 |
649 |
| Advisory Board of Medical Experts Support Use of Nymox Alzheimer Test. |
|
|
Jun 11, 1998 |
644 |
| Molecular Biosystems and Mallinckrodt Report on Phase II Perfusion Studies for OPTISON. |
|
|
Jun 11, 1998 |
645 |
| Sparta Pharmaceuticals, Inc. Receives FDA Approval to Begin Phase II/III Spartaject(TM) Busulfan Clinical Trials. |
|
|
May 28, 1998 |
588 |
| SUGEN Presents Clinical Results on SU101 and SU5416 at ASCO. |
|
|
May 18, 1998 |
918 |
| Article in Leading Scientific Journal Spotlights Use of Genta's bcl-2 Antisense Compound in Increasing Response to a Chemotherapeutic Drug. |
|
|
Feb 2, 1998 |
901 |
| Asensio & Co.: Zonagen's Vasomax Patent Application Exposed. |
|
|
Jan 14, 1998 |
408 |
| Clinical Research Finds A Way To Reverse Memory Loss; Is A "Memory Cocktail" On The Way? |
|
|
Sep 11, 1997 |
418 |
| U.S. Phase III Clinical Results Are Reported For the KeraVision Ring; 97 Percent Of Patients Treated For Nearsightedness Achieved 20/40 Vision Or Better. |
|
|
Sep 8, 1997 |
612 |
| Organogenesis Receives FDA Marketing Clearance for GRAFTPATCH Surgical Product. |
|
|
Aug 8, 1997 |
474 |
| Boston Life Sciences Initiates Development of Its Anti-Angiogenic Product for Ophthalmic Indications. |
|
|
Jul 16, 1997 |
321 |
| SangStat and Gensia Sicor Announce FDA Approval of Bulk Cyclosporine Drug Substance; SangStat's Marketing Application for Finished Cyclosporine Drug Product Under Review at FDA. |
|
|
Jul 7, 1997 |
937 |
| Correcting and replacing Quadratech announcement issued Monday, June 16. |
|
Correction Notice |
Jun 17, 1997 |
360 |
| ID Biomedical's subsidiary ID Vaccine acquires rights to new vaccine technology. |
|
|
Jun 13, 1997 |
835 |
| CardioTech International, Inc. announces ChronoFlex chosen for pioneering cardiac devices. |
|
|
May 6, 1997 |
426 |
| GENEMEDICINE announces the development of a negative GeneSwitch for use in gene therapy and functional genomics research. |
|
|
May 5, 1997 |
779 |
| COR Therapeutics, Inc. Receives Action Letter From FDA. |
|
|
Mar 25, 1997 |
411 |
| Harvard Scientific unveils alternative treatment for sexual enhancement and male erectile dysfunction: an exclusive interview by Kostech SmallCap Research. |
|
|
Mar 6, 1997 |
1503 |
| COR Therapeutics, Inc. Announces Results of FDA'S Advisory Committee Meeting. |
|
|
Mar 3, 1997 |
377 |
| Penederm Incorporated Receives United Kingdom Approval for Prescription Acne Product; Retinoic Acid with TopiCare Delivery Compound Approved. |
|
|
Feb 13, 1997 |
473 |
| Agouron getting ready to make biotech history. |
Acello, Richard |
|
Jan 20, 1997 |
534 |
| Neoprobe's First RIGS Product Receives Approval in South Korea. |
|
|
Jan 13, 1997 |
574 |
| SangStat's CYCLOSPORINE Is Bioequivalent to Sandoz' Newest Cyclosporine Formulation, Neoral; Neoral Has Become The Most Commonly Used Formulation Of Cyclosporine In Transplantation. |
|
|
Jan 9, 1997 |
1013 |
| FDA Clears Genentech's Nutropin Human Growth Hormone for Use in Turner Syndrome Patients. |
|
|
Dec 30, 1996 |
278 |
| FDA grants marketing approval for CellPro's CEPRATE SC Stem Cell Concentration System. |
|
|
Dec 6, 1996 |
695 |
| North American Vaccine Announces Update On FDA Advisory Committee Meeting. |
|
|
Nov 26, 1996 |
558 |
| SEQUUS Pharmaceuticals receives U.S. FDA market clearance for AMPHOTEC. |
|
|
Nov 25, 1996 |
493 |
| Infant formula containing Martek's DHA is introduced in fifth European market. |
|
|
Nov 12, 1996 |
590 |
| Unisys Information Services Group applying Biometric imaging: A perfect match. |
|
|
Oct 31, 1996 |
760 |
| Bio-Technology General announces approval of human growth hormone in Brazil. |
|
|
Oct 8, 1996 |
223 |
| LIFECELL'S ALLODERM DERMAL TISSUE CLASSIFIED AS "BANKED HUMAN TISSUE" BY FDA. |
|
|
Sep 23, 1996 |
457 |
| BioTime's Hextend cleared for Phase III clinical trials. |
|
|
Aug 19, 1996 |
251 |
| Ethyol's labeling expanded in Europe. |
|
|
Aug 7, 1996 |
201 |
| National Cancer Institute starts clinical trial of RMP-7; Pediatric brain tumor targeted in new study. |
|
|
Aug 5, 1996 |
385 |
| Harvard Scientific Corp. begins Phase I clinical trials. |
|
|
Aug 5, 1996 |
255 |
| Universal Genetics Announces Increased Ranking Of Top Holstein Bull. |
|
|
Jul 23, 1996 |
168 |
| Genta announces collaboration with National Cancer Institute for its Anticode drug G3139. |
|
|
Jul 8, 1996 |
605 |
| Bio-Technology General files BioLon with FDA. |
|
|
Jun 27, 1996 |
415 |
| Pivotal trial in rheumatoid arthritis begun by Cypress Bioscience; company establishes rheumatology advisory board. |
|
|
Jun 26, 1996 |
685 |
| Cypress Bioscience describes extramural research program; company establishes Immunology Advisory Board. |
|
|
Jun 26, 1996 |
692 |
| Lilly's Humalog -- first new insulin in 14 years -- approved for marketing by U.S. Food and Drug Administration. |
|
|
Jun 17, 1996 |
1212 |
| National Cancer Institute researchers show new drug combination kills cancer cells resistant to conventional drug therapies. |
|
|
Jun 12, 1996 |
378 |
| AMPLICOR HIV-1 MONITOR Test first to receive FDA approval for marketing; Test measures quantity of HIV-1 RNA in blood. |
|
|
Jun 3, 1996 |
772 |
| New study documents improvements in quality of life for dialysis patients. |
|
|
May 16, 1996 |
1008 |
| Allergic to biotech? |
Liebman, Bonnie |
Brief Article |
May 1, 1996 |
291 |
| Swedish study shows exceptional performance for fast SALV HIV test. |
|
|
Apr 15, 1996 |
609 |
| Ultrafem to proceed to clinical trials with BufferGel technology to offer women protection against AIDS; FDA has permitted BufferGel to enter Phase I clinical trials to begin in summer 1996; JHU/ReProtect, LLC receives $2 million in NIH grants for BufferGel development. |
|
|
Apr 10, 1996 |
722 |
| IMUTEC Corporation Clears FDA for US Phase I/II Clinical Trial in Pancreatic Carcinoma. |
|
|
Apr 9, 1996 |
263 |
| Merck & Co. Inc. receives FDA license to market Vaqta, hepatitis A vaccine. |
|
|
Apr 2, 1996 |
1296 |
| CORNELL UNIVERSITY STUDY REPORTS IMPROVED WOUND HEALING WITH LIFECELL PRODUCT; Wound Contraction Decreased and Cosmetic Appearance Improved. |
|
|
Mar 28, 1996 |
389 |
| Caution advised on new Alzheimer's tests. |
|
|
Mar 27, 1996 |
375 |
| STUDY REPORTS LIFECELL'S XENODERM PROVIDES DERMAL MATRIX FOR RECONSTITUTED SKIN. |
|
|
Mar 25, 1996 |
328 |
